The Russell 2000 Index has soared, but you -2-
Provided by
Dow Jones
Omega Therapeutics Inc. OMGA 100% $3.01 $12.00 299%
Allogene Therapeutics Inc. ALLO 82% $3.21 $12.79 298%
X4 Pharmaceuticals Inc. XFOR 86% $0.84 $3.26 289%
Caribou Biosciences Inc. CRBU 89% $5.73 $22.25 288%
Stoke Therapeutics Inc. STOK 78% $5.26 $19.33 268%
Source: FactSet
That's right - this Russell 2000 list is all biotech. And in case you are wondering if any companies are on both lists, the answer is now.
Don't miss: 11 dividend stocks with high yields expected to be well supported in 2024 per strict criteria
-Philip van Doorn
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-02-24 1226ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom